RankingsPricing
  1. US-listed companies
  2. STAAR SURGICAL CO
  3. Financials
  4. Cash and cash equivalents

STAAR SURGICAL COSTAA

Market cap
$1.3B
P/E ratio
SummaryFinancials
Period EndCash and cash equivalents (Million USD)YoY (%)
Dec 27, 2024144-21.24%
Dec 29, 2023183+111.65%
Dec 30, 202286-56.70%
Dec 31, 2021200+31.00%
Jan 1, 2021152+27.08%
Jan 3, 2020120+15.35%
Dec 28, 2018104+457.90%
Dec 29, 201719+33.16%
Dec 30, 201614+4.45%
Jan 1, 201613+2.99%
Jan 2, 201513-43.31%
Jan 3, 201423+38.43%
Dec 30, 201117

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)